Suttie J W, Larson A E, Canfield L M, Carlisle T L
Fed Proc. 1978 Oct;37(12):2605-9.
It has been postulated that the liver microsomal conversion of vitamin K hydroquinone to its 2,3-epoxide (epoxidase activity) is coupled in some obligatory fashion to the vitamin K-dependent carboxylation (carboxylase activity) event also occurring in microsomes. This hypothesis is supported by the observations that the requirements for the two reactions are similar and that conditions that promote increased carboxylation increase the epoxidase activity. It has now been shown that both of these reactions are localized in the rough microsomal fraction of a cellular homogenate, and that both activities appear to be located on the luminal rather than the outer surface of microsomal membrane vesicles. The epoxidase activity has been found to be enriched as the microsomal carboxylase activity is fractionated, and a microsomal inhibitor of the carboxylase activity had been shown to also inhibit the epoxidase activity. The enzyme glutathione peroxidase inhibits both of these activities, suggesting that a hydroperoxide of the vitamin might be an intermediate for both reactions. The organic hydroperoxide t-butyl-OOH has also been shown to have weak vitamin K-like activity in an in vitro system. These data strengthen the hypothesis that these two reactions are related, perhaps through a common intermediate, but do not provide a definite molecular role for this interrelationship.
据推测,肝脏微粒体中维生素K对苯二酚向其2,3 -环氧化物的转化(环氧化酶活性)以某种必然的方式与同样发生在微粒体中的维生素K依赖性羧化作用(羧化酶活性)相关联。这一假说得到了以下观察结果的支持:这两种反应的条件要求相似,且促进羧化作用增强的条件会增加环氧化酶活性。现已表明,这两种反应都定位于细胞匀浆的粗面微粒体部分,且两种活性似乎都位于微粒体膜囊泡的腔面而非外表面。已发现随着微粒体羧化酶活性的分级分离,环氧化酶活性也会富集,并且已证明一种羧化酶活性的微粒体抑制剂也能抑制环氧化酶活性。谷胱甘肽过氧化物酶可抑制这两种活性,这表明维生素的一种氢过氧化物可能是这两种反应的中间体。在体外系统中,有机氢过氧化物叔丁基过氧化氢也已被证明具有微弱的维生素K样活性。这些数据强化了这两种反应相关的假说,可能是通过一个共同中间体,但并未为这种相互关系提供明确的分子作用。